Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,199.8
26.9 (0.85%)

 

  • STI Straits Times Index
    3,199.8
    26.9 (0.85%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,570.3
    7.1 (0.45%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,981.1
    335.7 (1.26%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,920.1
    -4.3 (-0.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,441.8
    49.9 (0.21%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,191.2
    11.1 (0.18%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,131.8
    26.1 (1.24%)
    Index delayed 20 minutes
  • XAO XAO
    6,806.4
    -46.8 (-0.68%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 248.7M
  • Value: 353.5M
  • Rise: 113
  • Fall: 80
  • Unch: 633

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.173+0.006
Tritech0.025+0.002
Golden Agri-Res0.220-0.005
Mapletree NAC Tr1.140-0.020
Dyna-Mac0.126+0.006
YZJ Shipbldg SGD1.100+0.020
Suntec Reit1.820-0.010
Mapletree Com Tr2.310-0.020
GSS Energy0.081+0.003
Broadway Ind^0.065+0.003

World Indices

World Indices
Name Last Change
Nasdaq 8,654.1 +37.9
HSI 27,010.5 +365.1
HSCEI 10,641.8 +139.3
Jakarta 6,196.6 +16.5
Nikkei 225 23,443.1 +51.2
SSE Comp 2,921.2 -3.3
Shanghai A 3,060.9 -3.4
Shanghai B 242.5 -1.6
PSE Comp 0.0
KOSPI 2,135.4 +29.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

FRONTAGE FRONTAGE
Quotes 15 Minutes Delayed. Updated at 12 Dec 2019 10:40
Last (HKD): 4.170 Change: +0.020 High: 4.180 Remarks: -
Change (%): +0.48 Low: 4.120
Open 4.180 Yesterday's Close 4.150
Buy Price 4.170 Sell Price 4.180
Buy Volume ('000) 32 Sell Volume ('000) 114
Cumulative Volume ('000) 758 Cumulative Value 3,142,400
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.04388 Trailing EPS (HKD) e 0.04388 NAV (HKD) b 0.9624
PE a 95.032 Trailing PE f 95.025 Price / NAV b 4.3329
Dividend (HKD) d - Cash In Hand (HKD) g 0.8273 Issued & Paid-up Shares c 2,007,640,000
Dividend Yield (%) d - Price / Cash In Hand g 5.040 Treasury Shares h -
Beta - 75 Daysi 1.274 R-Squared - 75 Days(%)i 10.91 Market Cap (M) 8,371.859
Beta - 500 Daysi 1.081 R-Squared - 500 Days (%)i 10.82 Enterprise Value (M) 6,863.562
Piotroski F Score 5 Exchange Code 1521 Par Value ( USD ) n.a.
52 Weeks Volatility (%) n.a. 6-Month VWAP 4.194 Free Float (%) 36.3
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 31 May 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 23 May 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference FRONTAGE HKEx 8,371.859 95.032 95.025 4.3329 -
Industry Biotechnology HKEx 47,663.213 14.027 14.981 5.9708 2.605
Local Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Local Peer SINO BIOPHARM HKEx 129,562.909 12.092 12.549 3.8585 0.710
Local Peer WUXI BIO HKEx 119,069.031 159.417 124.627 12.2566 -
Local Peer BEIGENE HKEx 86,221.775 - - 8.6028 -
Local Peer GENSCRIPT BIO HKEx 35,422.184 213.019 - 9.9889 -
Local Peer 3SBIO HKEx 26,669.685 17.630 21.458 2.6286 -
Local Peer HAOHAI BIOTEC HKEx 13,120.085 26.721 29.614 3.0890 0.793
Local Peer CKLIFE SCIENCES HKEx 7,688.856 29.240 29.199 1.8416 1.250
Local Peer VIVA BIOTECH HKEx 6,717.210 62.629 62.630 3.4873 -
Local Peer ASCENTAGE-B HKEx 6,367.256 - - -3.4479 -
Local Peer SINOMAB BIO-B HKEx 4,055.147 - - - -
Local Peer ASCLETIS-B HKEx 3,731.898 - - 0.9682 -
Other Local Peers ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 139,044.998 16.565 17.236 12.7249 2.391
Global Peer CSL ASX 128,058.856 47.731 47.731 17.1130 0.940
Global Peer GILEAD SCIENCES INC NASDAQ 85,751.867 15.720 31.843 4.1619 3.409
Global Peer VERTEX PHARMACEUTICAL NASDAQ 56,573.000 26.986 26.390 10.7688 -
Global Peer BIOGEN INC NASDAQ 52,730.566 11.901 9.773 3.7676 -
Global Peer ILLUMINA INC NASDAQ 47,123.790 57.051 48.431 10.6158 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,012.089 16.778 19.127 3.9043 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,815.821 81.695 24.104 5.4372 0.734
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,231.364 312.259 16.481 2.3373 -
Global Peer INCYTE CORPORATION NASDAQ 20,447.637 186.749 50.492 8.4406 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), 10X GENOMICS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), Lonza (SGX), IMMUNOMEDICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), NATERA INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), UNIQURE N.V. (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), SYNTHORX INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), REGENXBIO INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), FATE THERAPEUTICS (NASDAQ), NEXTCURE INC (NASDAQ), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), TG THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INTREXON CORP (NASDAQ), CORTEXYME INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), POLYNOVO LIMITED (ASX), MEIRAGTX HOLDINGS PLC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), XBIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), OMEROS CORP (NASDAQ), MESOBLAST LTD (ASX), INTRA-CELLUAR THERAPIES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), RETROPHIN INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), IMMUNOGEN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), AGENUS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MACROGENICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), RECRO PHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), COMPUGEN (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), KAMADA (NASDAQ), PERSONALIS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), ELOXX PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), PFENEX INC (NYSE American), ADMA BIOLOGICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), NEXT SCIENCE LTD (ASX), DPHARMA (Bursa), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CHIASMA INC (NASDAQ), IVERIC BIO INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), XOMA CORP (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), AFFIMED N V (NASDAQ), NANTKWEST INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NANOVIRICIDES INC (NYSE American), ENZO BIOCHEM INC (NYSE), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CHIMERIX INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), FENNEC PHARMACEUTICALS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), SESEN BIO INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), PARATEK PHARMACEUTICALS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), IMUGENE LIMITED (ASX), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), SYNLOGIC INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFLARX N V (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), EQUILLIUM INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), VERMILLION INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), CEL-SCI CORP (NYSE American), ITERUM THERAPEUTICS PLC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), SURFACE ONCOLOGY INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), RESTORBIO INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ORGENESIS INC (NASDAQ), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), BELLICUM PHARMACEUTICALS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ISORAY INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), BIONOMICS LTD (ASX), EVOGENE LTD (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), NOVITA HEALTHCARE LTD (ASX), ORAGENICS INC (NYSE American), VISTAGEN THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), MEMPHASYS LTD (ASX), SOLIGENIX INC (NASDAQ), BIOTRON (ASX), IBIO INC (NYSE American), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), IMMURON LIMITED (ASX), DARE BIOSCIENCE INC (NASDAQ), CELLMID LIMITED (ASX), ADVAXIS INC (NASDAQ), VAXART INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), TOCAGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), OCUGEN INC (NASDAQ), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), ADALTA LTD (ASX), CCP TECHNOLOGIES LTD (ASX), TROVAGENE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), MEGASUN (Bursa), AUSTRALIAN PRIMARY HEMP LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), MGRC (Bursa), ACHIEVE LIFE SCIENCE INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), MEDIBIO LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), BIOCEPT INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SPHERIX INC (NASDAQ), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), BPH ENERGY LIMITED (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-0.71 %
10 Days --0.380
-8.35 %
20 Days --0.430
-9.35 %
Medium Term Return 3 Months -+0.150
+3.73 %
6 Months -+1.010
+31.96 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2.890 - 5.830 Change From 1 Year Low +1.280 % Change From 1 Year Low (%) +44.29
Change From 1 Year High -1.660 % Change From 1 Year High (%) -28.47
2 Years Range 2.890 - 5.830 Change From 2 Years Low +1.280 % Change From 2 Years Low (%) +44.29
Change From 2 Years High -1.660 % Change From 2 Years High (%) -28.47
5 Years Range 2.890 - 5.830 Change From 5 Years Low +1.280 % Change From 5 Years Low (%) +44.29
Change From 5 Years High -1.660 % Change From 5 Years High (%) -28.47
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Frontage Holdings Corp. engages in the provision of research, analytical and development services throughout the drug discovery and development process. It operates through the USA and PRC segments. The USA segment includes the bioanalytical; chemistry, manufacturing and controls (CMC); drug metabolism and pharmacokinetic (DMPK); and safety and toxicology services in the USA. The PRC segment covers the bioanalytical and bioequivalence services in the PRC. The company was founded by Song Li in 2001 and is headquartered in Exton, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
11 Dec 2019 4.100 4.270 4.100 4.150 3,990,000 4.1912
10 Dec 2019 4.170 4.260 4.070 4.140 7,142,000 4.2210
09 Dec 2019 4.150 4.210 4.040 4.140 5,212,000 4.1392
06 Dec 2019 4.180 4.220 4.100 4.160 6,278,000 4.1550
05 Dec 2019 4.200 4.370 4.120 4.190 6,932,000 4.2537
04 Dec 2019 4.170 4.290 4.130 4.200 1,378,000 4.2053
03 Dec 2019 4.130 4.280 4.120 4.200 3,932,000 4.2109
02 Dec 2019 4.190 4.230 3.970 4.130 12,542,193 4.1022
29 Nov 2019 4.310 4.340 4.070 4.140 11,249,800 4.1608
28 Nov 2019 4.480 4.550 4.330 4.380 5,364,000 4.4117
27 Nov 2019 4.440 4.570 4.350 4.550 10,478,000 4.4691
26 Nov 2019 4.480 4.590 4.400 4.440 3,795,700 4.4823
25 Nov 2019 4.550 4.690 4.460 4.480 5,612,000 4.5763
22 Nov 2019 4.640 4.640 4.490 4.540 11,362,222 4.5490
21 Nov 2019 4.780 4.830 4.630 4.640 4,805,017 4.6920
20 Nov 2019 4.960 5.090 4.820 4.850 5,746,773 4.9135
19 Nov 2019 4.720 5.150 4.710 5.020 9,576,096 4.9880
18 Nov 2019 4.860 4.870 4.580 4.770 5,614,040 4.7152
15 Nov 2019 4.650 4.970 4.570 4.820 13,558,000 4.8005
14 Nov 2019 4.650 4.740 4.480 4.600 9,626,000 4.6063
13 Nov 2019 4.610 4.800 4.500 4.600 6,800,000 4.6372
12 Nov 2019 4.830 4.840 4.600 4.710 8,514,000 4.6800
Summary
Current 2 Weeks
(28 Nov 2019 to 11 Dec 2019)
4.480 4.550 3.970 4.150 64,019,993 -
Previous 2 Weeks
(14 Nov 2019 to 27 Nov 2019)
4.650 4.740 3.970 4.550 80,173,848 -
4 Weeks from
(17 Oct 2019 to 13 Nov 2019)
5.430 5.560 3.970 4.600 125,120,760 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.